• Bile Acid Retention Disrupts Antigen Presentation in MASH-HC

  2026-06-10

  This study uncovers a mechanistic link between bile acid retention and impaired antigen presentation in metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma (MASH-HCC). The findings demonstrate that targeting bile acid metabolism can restore tumor immunogenicity and enhance response to immune checkpoint blockade, offering new directions for immunotherapy-resistant liver cancer.

• ECL Chemiluminescent Substrate Detection Kit: Sensitivity &

  2026-06-10

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) offers low picogram sensitivity for immunoblotting via horseradish peroxidase (HRP) chemiluminescence. Its extended signal duration and low background are optimized for detection of low-abundance proteins on nitrocellulose or PVDF membranes. The kit enables robust, reproducible protein detection and streamlined workflows for research applications.

• Pemetrexed in Translational Oncology: Mechanisms, Models, an

  2026-06-09

  This article explores how pemetrexed, a multi-targeted antifolate, is reshaping translational cancer research. By integrating mechanistic insights, gene expression profiling, and practical workflow guidance, it provides strategic recommendations for researchers tackling drug resistance and DNA repair vulnerabilities in malignant mesothelioma and beyond.

• Clasto-Lactacystin β-lactone: Precision Proteasome Inhibitor

  2026-06-09

  Clasto-Lactacystin β-lactone empowers researchers with potent, irreversible proteasome inhibition for dissecting protein degradation in advanced models of viral inflammation, cancer, and neurodegeneration. This guide details data-backed workflows, cutting-edge applications, and troubleshooting strategies to maximize reliability in ubiquitin-proteasome pathway research.

• Phalloidin (B7678): Technical Use Guide for F-Actin Stabiliz

  2026-06-08

  Phalloidin (B7678) is used for high-affinity stabilization and imaging of filamentous actin in fixed or permeabilized samples, providing robust cytoskeleton visualization for cell biology research. It is not suitable for live-cell studies or experiments requiring reversible actin binding. Researchers should apply it where static analysis of actin structure is required.

• ETS1 Regulates Mitophagy in BPD via SENP2/HSPA8/FUNDC1 Axis

  2026-06-08

  This study identifies ETS1 as a novel transcriptional regulator that mitigates bronchopulmonary dysplasia (BPD) by suppressing mitochondrial damage-induced mitophagy through the SENP2/HSPA8/FUNDC1 pathway. The findings provide mechanistic insights into chaperone-mediated autophagy in neonatal lung disease, offering new molecular targets for therapeutic intervention.

• Axitinib (AG 013736): Selective VEGFR Inhibitor for Cancer R

  2026-06-07

  Axitinib (AG 013736) is a highly selective, orally bioavailable inhibitor of VEGFR1, VEGFR2, and VEGFR3. It demonstrates nanomolar potency in angiogenesis inhibition assays and robust tumor growth suppression in xenograft models, supporting precision cancer biology research.

• G007-LK Tankyrase 1/2 Inhibitor: Precision Tool for Wnt Path

  2026-06-06

  G007-LK is a nanomolar tankyrase 1/2 inhibitor enabling robust Wnt/β-catenin pathway inhibition and β-catenin degradation, especially in APC-mutant colorectal cancer and hepatocellular carcinoma research. This article presents actionable protocols, advanced troubleshooting, and key insights translating bench discoveries into reproducible workflows.

• Verteporfin (CL 318952): Applied Workflows for PDT & Autopha

  2026-06-05

  Verteporfin (CL 318952) stands apart as a dual-action photosensitizer and autophagy inhibitor, offering robust performance in photodynamic therapy and advanced cell biology assays. This guide delivers protocol-driven insights and troubleshooting strategies for maximizing reproducibility and data quality with Verteporfin from APExBIO.

• Carvacrol: Redox Modulation and Precision in TRP Channel Res

  2026-06-05

  Explore Carvacrol’s unique role as a monoterpene phenol in TRP channel and redox biology research. This article offers a deep dive into mechanistic insights, advanced assay design, and the implications of recent breakthroughs for cell cycle and apoptosis studies.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-06-04

  Schwartz’s dissertation introduces a rigorous distinction between relative and fractional viability in in vitro drug response assays, revealing how these metrics independently capture proliferative arrest and cell death. This nuanced approach can clarify the effects of apoptosis inducers, such as pan-Bcl-2 inhibitors, and improve assay interpretation for translational cancer research.

• MOG (35-55): Precision Modeling for Autoimmune Encephalomyel

  2026-06-04

  MOG (35-55) Peptide is the benchmark for reproducible EAE induction, enabling advanced dissection of autoimmune neuroinflammation and translational MS research. This guide delivers workflow enhancements, troubleshooting expertise, and actionable insights that leverage the latest mechanistic breakthroughs.

• IPR-803: Advanced Urokinase Receptor Inhibitor for Tumor Res

  2026-06-03

  IPR-803 empowers cancer researchers with precise, competitive inhibition of the uPAR-uPA axis. Its well-characterized performance in both breast and pancreatic cancer models, including advanced nanomedicine workflows, sets a new benchmark for dissecting metastasis and stroma modulation.

• ECL Chemiluminescent Substrate Detection Kit: Hypersensitive

  2026-06-03

  APExBIO's ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) revolutionizes immunoblotting by enabling detection of proteins at low picogram levels with extended signal duration and low background. Designed for both nitrocellulose and PVDF membranes, it empowers researchers to confidently analyze low-abundance targets, such as those required in advanced translational oncology workflows.

• USP7 Regulates Macrophage Polarization via PKM2 in Acute Pan

  2026-06-02

  This study uncovers how ubiquitin-specific protease 7 (USP7) modulates macrophage polarization and inflammatory responses in severe acute pancreatitis (SAP) through direct regulation of pyruvate kinase M2 (PKM2)-mediated metabolic reprogramming. The findings highlight a novel immunometabolic axis with potential implications for targeted therapies in SAP and related inflammatory conditions.

16375 records 1/1092 page Next 12345 下5页 Last page